Remote patient care company Preventice and remote cardiac monitoring devices maker eCardio Diagnostics announced this week that they would join forces and merge sales operations under a new holding company, Preventice Inc.
The new company combines Preventice’s commercially available wireless remote cardiac monitoring systems with eCardio’s national sales force and patient monitoring center.
"This strategic combination with Preventice will provide physicians with even greater access to products and services in the emerging market of cardiac remote patient care – one of the fastest growing segments in telehealth," eCardio founder & CEO Larry Lawson said in prepared remarks. "eCardio has focused on providing physician practices, academic medical centers and hospitals with the value-add tools they need to diagnose patients. In addition to mobile cardiac telemetry monitoring, streamlined reports via customized web portals, and successful EMR integrations, our customers can now look forward to a more robust and cost-effective offering."
Lawson will serve as chairman & CEO of the new Preventice Inc., and Preventice co-founder, president & CEO Jon Otterstatter will serve as president and global strategy officer, the companies announced. The company will be managed from eCardio’s corporate headquarters in Houston, but clinical research and product development will stay at Preventice’s Rochester, Minn., location.